Differential long-term benefit of adjuvant tamoxifen in ER+/HER2- premenopausal + postmenopausal BC VJOncology 2:55 1 year ago 2 356 Далее Скачать
In 2023, Is there a patient where adjuvant 5 years of tamoxifen is considered enough? Oncology me 1:08 1 year ago 124 Далее Скачать
Mary's Experience with Anti-Estrogen Therapy Breast Cancer Index 2:12 4 years ago 5 635 Далее Скачать
RxPONDER: 21-gene assay informs chemotherapy benefit in HR+ node-positive breast cancer VJOncology 0:38 2 years ago 188 Далее Скачать
25-year benefit from tamoxifen by clinically used breast cancer markers VJOncology 2:17 3 years ago 8 292 Далее Скачать
Key challenge associated with the management of HR+/HER2- breast cancer VJOncology 0:35 1 year ago 107 Далее Скачать
Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer ecancer 5:00 2 years ago 678 Далее Скачать
Non-adherence to tamoxifen in CANTO cohort over 3 years VJOncology 3:08 4 years ago 452 Далее Скачать
Adjuvant Hormone Therapy: Is Ten Years Better Than Five presented by Kathleen Fielder, MD Compass Oncology 28:09 9 years ago 860 Далее Скачать
Expert Tips on Tamoxifen for Premenopausal Women with Breast Cancer Learn Look Locate 0:58 1 year ago 121 Далее Скачать
Adjuvant Therapy | 2023 Best of Breast Conference Total Health | Oncology 46:31 1 year ago 6 810 Далее Скачать
If most breast cancers are driven by estrogen, why are peak incidences after menopause? Breast Cancer Research Foundation 1:11 10 years ago 5 582 Далее Скачать
The NEW Tamoxifen Guide JUST FOR Breast Cancer Survivors Dr Liz O'Riordan 10:29 1 year ago 29 196 Далее Скачать
GS2-04: "Aromatase inhibitors versus tamoxifen in pre-menopausal women with estrogen receptor..." San Antonio Breast Cancer Symposium 10:39 1 year ago 457 Далее Скачать
10-year results of a Phase III trial of low-dose tamoxifen in non-invasive breast cancer VJOncology 1:32 2 years ago 1 515 Далее Скачать
Common Side Effects of Hormonal Therapy #short Yerbba – Breast Cancer 0:37 2 years ago 2 310 Далее Скачать
